COMMUNIQUÉS West-GlobeNewswire

Cannara obtient les droits exclusifs au Canada sur la technologie d’infusion Ampersand™ Live Rosin de Blue River
02/07/2026
Ce partenariat associe le leadership de Cannara dans le domaine du cannabis haut de gamme sans solvant à la technologie d’infusion exclusive de Blue River afin de proposer une nouvelle génération de produits à base de [...]
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
02/07/2026
CEO Shane Schaffer: Inclusion Demonstrates Continued Growth and Enhanced Visibility Among Institutional Investors KANSAS CITY, Kan., July 02, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical [...]
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
02/07/2026
BOULDER, Colo., July 02, 2026 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today announced that it will host a [...]
Qolab Announces $54.2 Million Series B Financing and Commitments Led by UC Investments to Accelerate the Future of Quantum Computing
02/07/2026
Announcement made during the 75th Lindau Nobel Laureate Meeting highlights growing collaboration among Qolab, Nobel Laureate Dr. John Martinis and the University of California innovation ecosystem SANTA BARBARA, Calif [...]
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
02/07/2026
Kirlew will lead Integra’s global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution. PRINCETON, N.J., July 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences [...]
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
02/07/2026
ROCKVILLE, MD, July 02, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, and [...]
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
02/07/2026
New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization [...]
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines
02/07/2026
NORTH PALM BEACH, Fla., July 02, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-conviction operating [...]
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
02/07/2026
REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]
LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS
02/07/2026
-Transaction Transforms LIXTE to New Growth Sector Addressing Multi-Billion-Dollar Market of Mobile, Utility-Grade Battery Energy Storage Systems- -Company Plans Corporate Name Change to NOMAD Power Solutions BOCA RATON [...]
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
02/07/2026
Taipei, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic [...]
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Cannabix Technologies Announces Detection of Methamphetamine and Amphetamine in Human Breath
02/07/2026
Methamphetamine & Amphetamine Detection in Breath Represents a Significant New Opportunity for Cannabix Technologies Inc. VANCOUVER, British Columbia, July 02, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
02/07/2026
Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), and change the listed company’s name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent) and “CRGT” [...]
New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring
02/07/2026
- Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal compression-related false lows from true blood glucose lows - Demonstrates [...]
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
02/07/2026
Findings from 14 studies involving more than 8,000 patients show Prolaris adds insight beyond conventional clinical risk categories SALT LAKE CITY, July 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN [...]
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
02/07/2026
- Presentation Highlights Business Progress, Product Development Milestones, and Matters for Stockholder Consideration- TUCSON, Ariz., July 02, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard [...]
Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion Technology
02/07/2026
Partnership combines Cannara's leadership in premium solventless cannabis with Blue River's proprietary infusion technology to bring a new generation of live rosin products to Canadian consumers MONTREAL, July 02, 2026 [...]
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026
02/07/2026
Abstract recently submitted in anticipation of initial data analysis ahead of ESC Company expects to report topline LEVEL results in August CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. ( [...]

Pages